Prosecution Insights
Last updated: October 04, 2026

The Chinese University of Hong Kong

Technology area: Biotechnology & Pharmaceuticals

30 pending office actions • 20 art units • 30 examiners • 0 of 30 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Analysis

The Chinese University of Hong Kong manages 29 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 29 actions are split among 29 distinct examiners, meaning every pending case is being reviewed by a different person. The portfolio is also diversified across 20 distinct art units, reflecting a range of research and development activities.

GHAZAL SABOUR is the busiest examiner for the university, with 1 pending office action. Because there is no concentration of cases with any single examiner, the university must manage 29 independent prosecution tracks. The 20 art units further complicate the prosecution landscape, as the university must navigate the specific requirements of many different technical divisions. This decentralized structure for 29 pending actions requires a coordinated legal effort to maintain a unified patent strategy across 20 art units. This variety in examiners and art units suggests that the university must maintain a flexible prosecution strategy to address the different standards across 20 distinct art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

30
Total Pending OAs
18
Non-Final OAs
9
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

18
Hard (60%)
11
Medium (37%)
1
Easy (3%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other9 (30%)
§103 only10 (33%)
§112 only1 (3%)
Double-patenting + other1 (3%)
Multi-statute (no §101)9 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
63% of docket
1
Information Tech
3% of docket
2
Communications
7% of docket
1
Semiconductors
3% of docket
2
Mechanical / Eng
7% of docket
5
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

300 h
Manual time on pending OAs
60 h
Time saved (low, 20%)
105 h
Time saved (mid, 35%)
2.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SABOUR, GHAZAL 1 37.8% +43.2%
OAKES, JUSTIN MONTGOMERY 1 — —
HSIEH, PING Y 1 79.1% +15.4%
FIEBIG, RUSSELL G 1 62.6% +25.0%
COLE, HOUSTON DAVID 1 — —
PALLAY, MICHAEL B 1 55.8% +34.0%
DEVI, SARVAMANGALA 1 65.3% +55.3%
MATHEW, SEEMA 1 71.4% +26.1%
FONSECA LOPEZ, FRANCINI ALVARENGA 1 29.6% +37.1%
JAUHARI, SACHI 1 60.0% +80.0%

Hard Cases (18)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17814911 LOW-CONCENTRATION ATROPINE FOR MYOPIA PREVENTION (LAMP-2) STUDY SHOWALTER, ALEXANDER KEITH 56d overdue
17247153 Methods for Inducing Intermittent Fasting and Modulating Autophagy DABKOWSKI, ERINNE R 46d overdue
18763336 SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM FIEBIG, RUSSELL G —
18667437 COMPOSITIONS AND METHODS RELATED TO PROTEIN LABELING COLE, HOUSTON DAVID —
18658479 NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS PALLAY, MICHAEL B —
18654339 COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT DEVI, SARVAMANGALA —
18597485 MODULAR FOOT CONTROLLED CABLE ACTUATED PROSTHESIS MATHEW, SEEMA —
18443879 EARLY DETECTION AND INTERVENTION OF AT-RISK SUBJECTS FOR PRODROMAL PARKINSON'S DISEASE FONSECA LOPEZ, FRANCINI ALVARENGA —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19272962 NON-INVASIVE DETECTION OF TISSUE ABNORMALITY USING METHYLATION SABOUR, GHAZAL 36d
19004686 FUSIONNET AND ENSEMBLE LEARNING-BASED ARTIFICIAL INTELLIGENCE SYSTEM FOR ALZHEIMER'S DISEASE CLASSIFICATION FROM OPTICAL COHERENCE TOMOGRAPHY THICKNESS AND DEVIATION MAPS HSIEH, PING Y —
18763336 SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM FIEBIG, RUSSELL G —
18658479 NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS PALLAY, MICHAEL B —
18654339 COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT DEVI, SARVAMANGALA —
18597485 MODULAR FOOT CONTROLLED CABLE ACTUATED PROSTHESIS MATHEW, SEEMA —
18443879 EARLY DETECTION AND INTERVENTION OF AT-RISK SUBJECTS FOR PRODROMAL PARKINSON'S DISEASE FONSECA LOPEZ, FRANCINI ALVARENGA —
18394367 METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES JAUHARI, SACHI —

Top Art Units

Art UnitApps
1686 3
1682 3
1654 2
2662 1
1617 1
1645 1
3774 1
1762 1
1677 1
2874 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19272962 NON-INVASIVE DETECTION OF TISSUE ABNORMALITY USING METHYLATION SABOUR, GHAZAL 1686 §103 Non-Final OA 36d Pending Jul 17, 2025
19069744 A METHOD OF ENHANCING DATASET FOR USE IN A MEDICAL DIAGNOSTIC SYSTEM, A METHOD FOR TRAINING A MEDICAL DIAGNOSTIC SYSTEM, AND A METHOD OF SYNTHESIZING VIDEO FOR MEDICAL DIAGNOSIS OAKES, JUSTIN MONTGOMERY 2662 §103 Non-Final OA — Pending Mar 04, 2025
19004686 FUSIONNET AND ENSEMBLE LEARNING-BASED ARTIFICIAL INTELLIGENCE SYSTEM FOR ALZHEIMER'S DISEASE CLASSIFICATION FROM OPTICAL COHERENCE TOMOGRAPHY THICKNESS AND DEVIATION MAPS HSIEH, PING Y — §103 Non-Final OA — Pending Dec 30, 2024
18763336 SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM FIEBIG, RUSSELL G — §103§112 Non-Final OA — Pending Jul 03, 2024
18667437 COMPOSITIONS AND METHODS RELATED TO PROTEIN LABELING COLE, HOUSTON DAVID — §103§112 Non-Final OA — Pending May 17, 2024
18658479 NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS PALLAY, MICHAEL B 1617 §103§112 Non-Final OA — Pending May 08, 2024
18654339 COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT DEVI, SARVAMANGALA 1645 §101§102§103 Non-Final OA — Pending May 03, 2024
18597485 MODULAR FOOT CONTROLLED CABLE ACTUATED PROSTHESIS MATHEW, SEEMA 3774 §102§103§112 Non-Final OA — Pending Mar 06, 2024
18443879 EARLY DETECTION AND INTERVENTION OF AT-RISK SUBJECTS FOR PRODROMAL PARKINSON'S DISEASE FONSECA LOPEZ, FRANCINI ALVARENGA — §101§112 Non-Final OA — Pending Feb 16, 2024
18394367 METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES JAUHARI, SACHI 1654 §102§103§112DP Non-Final OA — Pending Dec 22, 2023
18540667 METHODS AND COMPUTER PRODUCTS FOR MEASURING THE AMOUNT OF CELLS OF A PARTICULAR CELL LINEAGE MYERS, CARLA J 1682 §101§112DPOther Non-Final OA — Pending Dec 14, 2023
18495414 ADRM1/RPN13 SPLICED VARIANT IN THE PROGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA TURPIN, ZACHARY MARK 1682 §101§103§112 Non-Final OA — Pending Oct 26, 2023
18477775 CHAOTROPES-ASSISTED DEEP IMMUNOSTAINING NILAND, PATRICK DENNIS 1762 §102§103 Non-Final OA — Pending Sep 29, 2023
18243349 RAPID SCREENING METHODS FOR THYROID ASSOCIATED ORBITOPATHY HOFFMAN, ALEXANDER JOSEPH 1677 §103 Final Rejection — Pending Sep 07, 2023
18278594 HIGH COUPLING EFFICIENCY BLAZED WAVEGUIDE GRATING COUPLER ENDRESEN, KIRSTEN DANIELA 2874 §102§103 Final Rejection — Pending Aug 23, 2023
18257745 A METHOD FOR REVERSING AGING BRAIN FUNCTIONAL DECLINE LEE, JIA-HAI 1658 §102§103§112 Final Rejection — Pending Jun 15, 2023
18333872 REPURPOSED COMPOUND AS THERAPEUTIC FOR HPV-ASSOCIATED CANCERS MCANANY, JOHN D 1625 §103 Non-Final OA — Pending Jun 13, 2023
18326154 FRAMEWORK FOR PROTEIN DESIGN FROM PARTIAL SEQUENCE WITH MEMORY-EFFICIENT GLOBAL ATTENTION METHOD HILL, GRACELYN MARKHAM — §101§103 Non-Final OA — Pending May 31, 2023
18037693 ASSESSING RISK FOR COLORECTAL ADENOMA RECURRENCE BY NONINVASIVE MEANS VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §101§103§112Other Final Rejection — Pending May 18, 2023
18163359 THREE-DIMENSIONAL ARTIFICIAL INTELLIGENCE-AIDED CLASSIFICATION SYSTEM FOR GLAUCOMATOUS OPTIC NEUROPATHY AND MYOPIC OPTIC DISC MORPHOLOGY FROM OPTICAL COHERENCE TOMOGRAPHY SCANS DULANEY, BENJAMIN O 2683 §103 Non-Final OA — Pending Feb 02, 2023
17991701 CODON DE-OPTIMIZATION OR OPTIMIZATION USING GENETIC ARCHITECTURE STUBBS, JOHN THOMAS 1686 §101§102§103§112 Non-Final OA — Pending Nov 21, 2022
17933753 METHODS AND COMPOSITIONS FOR PROCESSING BOTANICAL MATERIALS GREENE, CAROLYN LEE 1681 §112 Final Rejection 97d overdue Pending Sep 20, 2022
17802751 ACTIVATION OF LYTIC GENES IN CANCER CELLS ZAHORIK, AMANDA MARY 1636 §103 Non-Final OA — Pending Aug 26, 2022
17814911 LOW-CONCENTRATION ATROPINE FOR MYOPIA PREVENTION (LAMP-2) STUDY SHOWALTER, ALEXANDER KEITH 1629 §103§112 Final Rejection 56d overdue Pending Jul 26, 2022
17742749 SIZE-BASED GENOMIC ANALYSIS ELKINS, BLAKE HARRISON 1687 §103 Non-Final OA 10d overdue Pending May 12, 2022
17533991 HYDROGEL-BASED 3D CELL TRAINING BIOREACTOR HURST, JONATHAN M 1799 §103 Final Rejection 8d overdue Pending Nov 23, 2021
17313880 SIZE-BASED ANALYSIS OF CELL-FREE TUMOR DNA FOR CLASSIFYING LEVEL OF CANCER VANNI, GEORGE STEVEN 1686 §101§103§112DP Non-Final OA — Pending May 06, 2021
17247153 Methods for Inducing Intermittent Fasting and Modulating Autophagy DABKOWSKI, ERINNE R 1654 §102§112 Final Rejection 46d overdue Pending Dec 02, 2020
16949581 METHOD FOR RECOGNIZING A MOTION PATTERN OF A LIMB LOPEZ, SEVERO ANTON P 3791 §103 Non-Final OA 51d overdue Pending Nov 04, 2020
17062387 PREDICTION MODELS INCORPORATING STRATIFICATION OF DATA ALGHAZZY, SHAMCY 2128 §101§103 Final Rejection — Pending Oct 02, 2020

Managing The Chinese University of Hong Kong's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month